Hub : Traits :

Smoking Status

742 significantly associated models · 197 unique genes.

Significant Loci

# chr p0 p1 # assoc genes # joint genes best TWAS P best SNP P cond SNP P % var exp joint genes
1 1 7715776 9571422 2 1 3.5e-10 1.4e-08 9.2e-01 100 RERE
2 1 31494475 32929175 1 1 4.9e-08 1.8e-08 1.0e+00 100 BAI2
3 1 33030461 34592020 2 1 3.8e-09 2.9e-09 1.0e+00 100 PHC2
4 1 43152610 45109101 3 1 8.2e-10 1.4e-13 3.2e-06 60 ST3GAL3
5 1 48301764 51180660 1 1 2.6e-08 1.9e-11 4.9e-05 63 AGBL4
6 1 66019891 67086881 1 1 6.2e-11 4.5e-11 2.2e-02 88 PDE4B
7 1 153496711 154944156 2 1 7.2e-12 1.3e-11 5.6e-03 83 HAX1
8 2 43417083 45864710 2 2 5.1e-19 8.5e-19 1.0e+00 100 LRPPRC RP11-89K21.1
9 2 47224927 48727280 1 1 2.2e-07 4.3e-06 8.5e-01 100 MSH6
10 2 161297929 162790882 1 1 3.1e-09 7.0e-09 4.9e-03 76 TANK
11 2 200553557 201060216 1 1 1.6e-07 1.3e-07 1.0e+00 100 C2orf60
12 3 24941038 26396178 1 1 1.8e-08 1.4e-08 1.0e-08 -2 TOP2B
13 3 48012797 51043528 26 2 1.9e-11 2.8e-09 5.5e-02 90 HYAL3 RHOA
14 3 51616334 53778875 12 1 1.2e-08 3.3e-09 1.0e+00 100 PPM1M
15 3 84317575 86808226 1 1 4.4e-20 4.7e-18 7.5e-01 100 CADM2
16 5 59353199 61145102 3 1 1.5e-09 9.3e-10 4.7e-02 90 ELOVL7
17 5 86867897 88427942 1 1 6.1e-08 1.7e-09 7.9e-03 81 TMEM161B-AS1
18 5 169590807 171533656 2 1 3.6e-08 9.7e-09 1.0e+00 100 NPM1
19 6 36751245 38162310 2 1 3.6e-08 4.4e-09 7.2e-03 79 C6orf129
20 6 110588546 112621834 5 1 1.9e-19 2.1e-20 8.0e-03 92 GTF3C6
21 7 1181139 2580275 2 2 2.6e-09 5.2e-10 2.8e-01 97 AC110781.3 KIAA1908
22 7 2646223 5003373 1 1 8.2e-09 1.6e-11 3.8e-06 53 SDK1
23 7 96405380 96896364 1 1 3.0e-08 5.9e-12 6.9e-06 57 DLX5
24 7 98244565 99751521 3 1 1.7e-09 6.2e-09 4.2e-01 98 CPSF4
25 7 109603832 111895681 1 1 2.2e-07 1.6e-07 1.0e+00 100 IMMP2L
26 7 116660803 118518479 2 2 7.9e-14 5.0e-14 1.0e+00 100 CTTNBP2 NAA38
27 8 26648746 28100234 2 2 6.0e-20 9.9e-24 1.9e-04 86 CLU EPHX2
28 8 65812899 67199420 1 1 1.9e-07 4.4e-07 3.3e-02 82 CTD-3025N20.3
29 8 91282507 92689456 1 1 3.3e-08 1.9e-10 9.9e-04 73 RP11-122A3.2
30 9 126927285 129422783 9 6 6.1e-15 1.1e-13 NaN NaN ARPC5L GAPVD1 MAPKAP1 PPP6C
31 10 10349662 12076043 1 1 2.7e-09 2.8e-07 5.8e-02 86 CELF2
32 10 21087485 22724472 2 1 3.8e-08 4.3e-08 2.4e-01 95 CASC10
33 10 102864652 105910221 20 9 1.1e-22 1.3e-22 NaN NaN ACTR1A AS3MT BTRC C10orf32 NT5C2 RP11-18I14.10 WBP1L
34 11 16343081 18106069 3 1 1.3e-09 3.1e-10 7.8e-03 82 PIK3C2A
35 11 26818083 28416646 2 2 1.8e-07 2.0e-15 8.4e-10 40 BDNF-AS LIN7C
36 11 63417724 65186348 2 2 1.6e-07 6.0e-07 3.7e-01 97 CCDC88B NRXN2
37 11 112135760 113846006 2 1 6.7e-14 3.6e-43 7.9e-32 27 NCAM1
38 11 133540722 134074099 1 1 7.9e-08 8.3e-08 1.0e+00 100 IGSF9B
39 12 55444736 57125879 5 1 6.8e-09 6.8e-08 8.8e-02 90 SUOX
40 12 108342014 109820777 1 1 1.1e-07 2.4e-07 1.8e-01 93 CORO1C
41 12 119870094 122037099 7 3 7.7e-10 3.1e-09 7.4e-01 100 C12orf43 COQ5 UNC119B
42 14 103289637 105211221 5 7 1.2e-09 2.5e-09 NaN NaN KLC1 PPP1R13B TDRD9 XRCC3
43 15 46780520 48764942 1 1 8.1e-13 3.8e-17 1.4e-09 48 SEMA6D
44 15 67138238 68789191 1 1 1.7e-07 3.4e-07 1.0e-02 74 MAP2K5
45 15 90730363 92135418 1 1 2.3e-07 7.1e-06 3.2e-01 95 FES
46 16 86671 1488646 13 1 1.5e-11 2.7e-11 1.8e-01 96 WDR24
47 16 30347731 31720486 1 1 4.5e-08 2.1e-07 6.9e-05 41 STX1B
48 16 69062879 70725815 5 2 1.4e-10 4.8e-11 2.0e-01 96 NOB1 PDXDC2P
49 16 89339571 89871168 1 1 1.4e-07 6.9e-07 8.3e-02 88 SPG7
50 17 1263564 2923933 2 1 1.1e-10 1.3e-09 3.9e-02 88 SRR
51 17 7577407 8066783 1 1 8.4e-08 2.3e-08 4.0e-02 86 KCNAB3
52 17 37137299 38547868 2 1 8.4e-08 8.2e-08 4.7e-02 86 PGAP3
53 17 44788310 45088455 1 1 3.0e-07 1.0e-04 2.8e-01 92 LRRC37A2
54 18 69836 907710 1 1 5.7e-08 9.5e-09 3.5e-02 87 USP14
55 20 30591354 32029439 1 1 1.7e-08 1.2e-10 7.2e-05 62 COMMD7
56 20 61576647 62912463 2 1 8.6e-08 9.5e-06 1.0e-01 86 RTEL1
57 21 46440385 46956571 1 1 1.7e-07 3.1e-07 3.0e-01 96 POFUT2
58 22 41181586 43674249 11 3 5.1e-11 4.0e-10 2.9e-03 77 CYP2D8P1 DESI1 RRP7B
59 22 45736153 47135205 2 1 1.6e-08 3.3e-08 8.5e-02 90 LINC00899

Pleiotropic Associations

Trait chisq ratio # genes+ # genes++ % genes++ corr corr P genes
Bipolar Disorder or Schizophrenia 3.91 14 11 24.4 0.13 6.1e-01 ACTR1A AS3MT C10orf32 FES IMMP2L KLC1 NT5C2 PGAP3 PPM1M PPP1R13B SPG7 ST3GAL3 TDRD9 XRCC3
Depressed Affect (Nagel 2018) 2.25 6 2 4.4 0.21 6.9e-01 CELF2 LRRC37A2 RERE RHOA RP11-122A3.2 TANK
Depression (Nagel 2018) 2.01 3 0 0.0 0.00 1.0e+00 LRRC37A2 RERE RP11-122A3.2
Intelligence (Savage-Jansen 2018) 2.34 10 3 6.7 -0.38 2.7e-01 ACTR1A CTD-3025N20.3 LRRC37A2 PPM1M RHOA ST3GAL3 SUOX TANK UNC119B XRCC3
Neuroticism (Nagel 2018) 2.62 11 2 4.4 -0.22 5.1e-01 AS3MT CELF2 CTTNBP2 GAPVD1 LRRC37A2 MAP2K5 NT5C2 PPM1M RERE RP11-122A3.2 TMEM161B-AS1
Schizophrenia (2018) 4.23 13 8 17.8 0.04 8.7e-01 ACTR1A AS3MT C10orf32 FES IMMP2L KLC1 NT5C2 PPM1M PPP1R13B RERE ST3GAL3 TDRD9 XRCC3
Worry (Nagel 2018) 3.57 13 7 15.6 -0.62 1.0e-02 ACTR1A AGBL4 AS3MT BTRC C10orf32 CADM2 CASC10 GAPVD1 LRRC37A2 MAP2K5 NT5C2 PPM1M TMEM161B-AS1
Alzheimer’s Disease (including proxy) 1.22 2 0 0.0 0.00 1.0e+00 CLU EPHX2
Crohns Disease (2017) 1.51 4 3 6.7 0.45 5.5e-01 CCDC88B FES PGAP3 RTEL1
Irritable Bowel Disease (IBD) 1.81 5 2 4.4 0.44 4.5e-01 CCDC88B FES PGAP3 RHOA RTEL1
Ulcerative Colitis (UC) 1.69 3 3 6.7 0.00 1.0e+00 PGAP3 RHOA RTEL1
Reaction Time 1.95 3 1 2.2 0.00 1.0e+00 AGBL4 COMMD7 RERE
Verbal and Numeric Reasoning (VNR) 2.19 5 1 2.2 -0.66 2.3e-01 DLX5 PPM1M ST3GAL3 SUOX TANK
Breast Cancer 1.17 2 1 2.2 0.00 1.0e+00 CASC10 LRRC37A2
Ovarian Cancer 1.37 2 2 4.4 0.00 1.0e+00 CASC10 LRRC37A2
Prostate Cancer 2.16 1 0 0.0 0.00 1.0e+00 WBP1L
Body Mass Index (BMI) (2010) 1.98 3 0 0.0 0.00 1.0e+00 BDNF-AS LIN7C MAP2K5
Coronary Artery Disease (CAD) 1.70 2 0 0.0 0.00 1.0e+00 AS3MT SPG7
Crohns Disease (2012) 1.64 3 1 2.2 0.00 1.0e+00 CCDC88B PGAP3 RTEL1
HDL Cholesterol 1.11 1 1 2.2 0.00 1.0e+00 PGAP3
Neuroticism (2016) 2.01 2 0 0.0 0.00 1.0e+00 LRRC37A2 TANK
Primary Biliary Cirrhosis 1.26 2 0 0.0 0.00 1.0e+00 CCDC88B PGAP3
Schizophrenia (2014) 4.18 17 9 20.0 0.14 5.4e-01 AC110781.3 ACTR1A AS3MT C10orf32 CLU FES IMMP2L KLC1 NT5C2 PIK3C2A PPM1M PPP1R13B RERE SPG7 ST3GAL3 TDRD9 XRCC3
Ulcerative Colitis 2.27 4 2 4.4 0.44 5.6e-01 COMMD7 PGAP3 RHOA RTEL1
Blood Eosinophil Count 1.25 14 6 13.3 0.20 4.7e-01 BDNF-AS CCDC88B DESI1 KCNAB3 LIN7C LRRC37A2 MAP2K5 PGAP3 PHC2 RERE SUOX TDRD9 UNC119B XRCC3
Blood Platelet Count 0.84 21 11 24.4 0.50 1.8e-02 AS3MT C10orf32 COMMD7 CORO1C CPSF4 CTD-3025N20.3 CYP2D8P1 MSH6 NT5C2 PGAP3 PHC2 PIK3C2A PPM1M RP11-18I14.10 RTEL1 SPG7 ST3GAL3 TOP2B UNC119B WBP1L WDR24
Blood Red Count 1.44 18 11 24.4 0.04 8.6e-01 AS3MT COMMD7 FES GTF3C6 HAX1 KCNAB3 KLC1 LRRC37A2 MAPKAP1 PGAP3 PPM1M RTEL1 SPG7 ST3GAL3 SUOX TDRD9 UNC119B XRCC3
Blood White Count 2.36 21 11 24.4 0.59 1.8e-03 ACTR1A AS3MT C10orf32 CPSF4 FES KCNAB3 KLC1 NT5C2 PDE4B PGAP3 PPP1R13B RERE RHOA RP11-18I14.10 RTEL1 SEMA6D SRR TDRD9 TMEM161B-AS1 WBP1L XRCC3
Heel T-Score 2.16 14 10 22.2 0.24 3.6e-01 AS3MT BDNF-AS CCDC88B HYAL3 KLC1 LINC00899 LRRC37A2 MSH6 NCAM1 PPP1R13B RERE SRR TDRD9 XRCC3
BMI 3.20 29 21 46.7 0.86 2.3e-10 ACTR1A AGBL4 AS3MT BAI2 BDNF-AS C2orf60 CADM2 CASC10 CPSF4 GTF3C6 HYAL3 KLC1 LIN7C MAP2K5 NOB1 NPM1 NRXN2 PDE4B PHC2 POFUT2 PPM1M PPP1R13B RHOA RTEL1 SRR STX1B SUOX TDRD9 XRCC3
Height 1.48 33 23 51.1 -0.20 2.3e-01 ARPC5L AS3MT BTRC C10orf32 CLU COQ5 CPSF4 DESI1 DLX5 GAPVD1 HYAL3 KCNAB3 KLC1 LINC00899 LRRC37A2 MAPKAP1 NCAM1 NOB1 NT5C2 PHC2 PIK3C2A PPM1M PPP1R13B RERE RHOA RP11-122A3.2 RP11-18I14.10 SPG7 ST3GAL3 TDRD9 WBP1L WDR24 XRCC3
Waist Hip Ratio (WHR) 1.49 10 4 8.9 0.08 8.2e-01 ARPC5L CCDC88B GAPVD1 LRRC37A2 MAPKAP1 MSH6 PPM1M PPP6C RHOA SEMA6D
Systolic Blood Pressure 3.03 18 10 22.2 -0.62 2.6e-03 AC110781.3 ACTR1A AS3MT BTRC C2orf60 CADM2 COQ5 FES GAPVD1 LIN7C MAPKAP1 NT5C2 PDXDC2P PIK3C2A RERE RP11-122A3.2 SPG7 SRR
Allergy or Eczema 2.25 7 5 11.1 -0.08 8.7e-01 PGAP3 RERE RP11-18I14.10 RTEL1 SUOX UNC119B WBP1L
Cardiovascular Disease 2.24 11 2 4.4 0.24 4.2e-01 AS3MT CCDC88B FES KLC1 MAP2K5 MAPKAP1 PPP1R13B RERE SUOX TDRD9 XRCC3
Hypothyroidism (self reported) 1.54 4 3 6.7 0.21 7.9e-01 CCDC88B RERE SUOX TANK
Respiratory disease 2.66 4 3 6.7 -0.25 7.5e-01 MAP2K5 PGAP3 RERE SUOX
Lung FEV1/FVC ratio 1.21 11 3 6.7 0.33 3.2e-01 ACTR1A CASC10 COMMD7 CORO1C CTTNBP2 HYAL3 LRRC37A2 MSH6 RERE SUOX TOP2B
Lung FVC 1.99 14 10 22.2 0.05 8.6e-01 AC110781.3 CASC10 LIN7C LRRC37A2 MAP2K5 MSH6 NOB1 PDXDC2P PGAP3 RTEL1 STX1B SUOX UNC119B USP14
Neuroticism 2.85 10 4 8.9 -0.30 3.6e-01 AS3MT CADM2 CTTNBP2 GAPVD1 LRRC37A2 MAP2K5 NT5C2 RERE RP11-122A3.2 TMEM161B-AS1
Chronotype (morning person) 1.99 5 0 0.0 -0.69 2.0e-01 BDNF-AS CYP2D8P1 DESI1 LIN7C TMEM161B-AS1
Hair Pigment 1.50 9 6 13.3 0.01 9.8e-01 FES KLC1 MSH6 PPP1R13B RERE SPG7 SUOX TDRD9 XRCC3
Tanning 2.21 7 3 6.7 0.66 7.5e-02 AS3MT CADM2 COMMD7 KIAA1908 MAPKAP1 PDE4B SPG7
Hand grip strength (left) 2.51 11 5 11.1 0.35 2.6e-01 ACTR1A ARPC5L AS3MT BTRC C10orf32 CADM2 GAPVD1 LRRC37A2 MAPKAP1 NOB1 PHC2
Number of treatments/medications taken 1.63 4 0 0.0 0.66 3.4e-01 CASC10 COMMD7 FES TANK
Sensitivity / hurt feelings 2.49 2 1 2.2 0.00 1.0e+00 GAPVD1 LRRC37A2
Frequency of depressed mood in last 2 weeks 1.87 3 0 0.0 0.00 1.0e+00 CELF2 LRRC37A2 RERE
Hearing difficulty/problems: Yes 1.74 1 0 0.0 0.00 1.0e+00 RP11-18I14.10
Relative age of first facial hair 2.13 3 1 2.2 0.00 1.0e+00 HYAL3 LRRC37A2 RRP7B
Ever had hysterectomy (womb removed) 1.13 1 0 0.0 0.00 1.0e+00 CASC10
Systolic blood pressure, automated reading 2.53 8 5 11.1 -0.72 2.8e-02 AS3MT FES GAPVD1 MAPKAP1 NT5C2 PDXDC2P RERE SRR
Angina 1.59 1 1 2.2 0.00 1.0e+00 FES
Diabetes (mother) 1.22 1 0 0.0 0.00 1.0e+00 COQ5
Pack years adult smoking proportion 3.14 5 1 2.2 0.98 2.3e-03 AGBL4 KLC1 PPP1R13B SEMA6D XRCC3
Impedance of leg (right) 1.98 22 6 13.3 -0.68 3.5e-04 ACTR1A AS3MT BDNF-AS C2orf60 CADM2 CPSF4 FES GAPVD1 HYAL3 KLC1 LIN7C NPM1 PHC2 PIK3C2A POFUT2 PPM1M PPP1R13B RHOA SEMA6D SUOX TDRD9 XRCC3
Leg fat-free mass (left) 2.18 20 10 22.2 0.63 1.2e-03 ACTR1A AGBL4 ARPC5L AS3MT BAI2 BDNF-AS C10orf32 C2orf60 CADM2 GAPVD1 LIN7C MAP2K5 NPM1 NT5C2 PDE4B PHC2 SPG7 STX1B SUOX WDR24
Trunk fat percentage 2.24 15 10 22.2 0.84 1.0e-04 AGBL4 BAI2 BDNF-AS BTRC CASC10 CPSF4 GTF3C6 LIN7C LRRC37A2 MAP2K5 NPM1 PDE4B RERE RTEL1 SRR
Hand grip strength (right) 2.06 8 3 6.7 -0.09 8.3e-01 ACTR1A ARPC5L CADM2 GAPVD1 LRRC37A2 MAPKAP1 NOB1 NPM1
Townsend deprivation index at recruitment 3.39 1 0 0.0 0.00 1.0e+00 CTTNBP2
Current tobacco smoking 8.52 26 9 20.0 0.98 1.2e-23 ACTR1A ARPC5L AS3MT C10orf32 C12orf43 CLU COQ5 CTTNBP2 DESI1 EPHX2 GAPVD1 GTF3C6 KLC1 MAPKAP1 PIK3C2A PPP1R13B PPP6C RERE RHOA RRP7B RTEL1 SEMA6D ST3GAL3 TDRD9 WBP1L XRCC3
Maternal smoking around birth 4.75 7 2 4.4 0.99 7.0e-07 ACTR1A AS3MT C10orf32 CASC10 PPP1R13B TDRD9 XRCC3
Fed-up feelings 1.72 4 2 4.4 0.71 2.9e-01 CCDC88B CTTNBP2 LRRC37A2 RHOA
Relative age voice broke 1.74 1 1 2.2 0.00 1.0e+00 LRRC37A2
Taking other prescription medications 1.78 1 0 0.0 0.00 1.0e+00 CCDC88B
Age when periods started (menarche) 2.44 8 4 8.9 -0.32 4.0e-01 BDNF-AS GAPVD1 MAP2K5 MSH6 NOB1 PPP6C ST3GAL3 SUOX
Heel bone mineral density (BMD) T-score, automated (left) 1.53 2 2 4.4 0.00 1.0e+00 RERE TDRD9
High blood pressure 2.28 8 1 2.2 -0.10 8.1e-01 FES MAP2K5 MAPKAP1 PDXDC2P RERE RP11-18I14.10 SRR SUOX
Hayfever, allergic rhinitis or eczema 2.10 6 5 11.1 0.00 9.9e-01 PGAP3 RERE RP11-18I14.10 RTEL1 SUOX WBP1L
Medication: Atenolol 1.34 1 1 2.2 0.00 1.0e+00 FES
Medication: Levothyroxine sodium 1.11 2 1 2.2 0.00 1.0e+00 CCDC88B SUOX
Sitting height 1.31 17 5 11.1 -0.19 4.4e-01 AC110781.3 ARPC5L C10orf32 CPSF4 FES GAPVD1 LRRC37A2 MAPKAP1 NCAM1 NOB1 NT5C2 PIK3C2A PPM1M RP11-18I14.10 SPG7 WBP1L WDR24
High blood pressure (mother) 1.79 1 1 2.2 0.00 1.0e+00 FES
Body mass index (BMI) 3.17 25 13 28.9 0.95 2.5e-14 ACTR1A AGBL4 AS3MT BAI2 BDNF-AS C2orf60 CADM2 CASC10 CPSF4 HYAL3 KLC1 LIN7C MAP2K5 NOB1 NPM1 PDE4B PHC2 PPM1M PPP1R13B RERE RHOA STX1B SUOX TDRD9 XRCC3
Impedance of leg (left) 2.02 21 6 13.3 -0.52 1.4e-02 ACTR1A ARPC5L AS3MT BDNF-AS CADM2 COMMD7 CPSF4 FES GAPVD1 HYAL3 KLC1 LIN7C NPM1 PHC2 PIK3C2A PPM1M PPP1R13B RHOA SEMA6D SUOX XRCC3
Leg predicted mass (left) 2.18 19 10 22.2 0.62 2.1e-03 ACTR1A AGBL4 ARPC5L AS3MT BAI2 BDNF-AS C10orf32 C2orf60 CADM2 GAPVD1 LIN7C MAP2K5 NPM1 NT5C2 PHC2 SPG7 STX1B SUOX WDR24
Trunk fat mass 2.39 17 10 22.2 0.93 1.6e-08 AGBL4 AS3MT BAI2 BDNF-AS CADM2 CASC10 CPSF4 LIN7C LRRC37A2 MAP2K5 NPM1 PDE4B PHC2 RERE RTEL1 SPG7 STX1B
Waist circumference 2.83 16 11 24.4 0.94 8.9e-08 AGBL4 AS3MT BAI2 BDNF-AS C2orf60 CADM2 CASC10 CPSF4 KLC1 LIN7C MAP2K5 NPM1 PDE4B PHC2 SPG7 STX1B
Number of incorrect matches in round 2.08 2 0 0.0 -0.06 9.4e-01 AS3MT C10orf32
Past tobacco smoking 10.65 48 18 40.0 -0.99 5.1e-42 AC110781.3 ACTR1A AS3MT C10orf32 C6orf129 CADM2 CASC10 CELF2 CLU COMMD7 CPSF4 CTD-3025N20.3 CTTNBP2 DLX5 ELOVL7 EPHX2 GAPVD1 GTF3C6 HAX1 HYAL3 KIAA1908 LIN7C LRPPRC MAP2K5 MSH6 NCAM1 NOB1 NPM1 NRXN2 NT5C2 PDE4B PDXDC2P PGAP3 PHC2 PPM1M PPP6C RP11-89K21.1 SDK1 SPG7 SRR STX1B SUOX TANK TDRD9 TMEM161B-AS1 TOP2B WBP1L WDR24
Alcohol usually taken with meals 2.82 3 0 0.0 0.00 1.0e+00 ACTR1A CLU CTTNBP2
Nervous feelings 3.44 11 5 11.1 -0.95 5.5e-07 ACTR1A AGBL4 AS3MT C10orf32 CADM2 LRRC37A2 MAP2K5 NT5C2 PPM1M SRR TMEM161B-AS1
Frequency of tenseness / restlessness in last 2 weeks 1.59 1 1 2.2 0.00 1.0e+00 LRRC37A2
Hearing difficulty/problems with background noise 2.42 4 1 2.2 0.99 1.9e-03 KLC1 RP11-18I14.10 WBP1L XRCC3
Hair/balding pattern: Pattern 2 1.36 1 0 0.0 0.00 1.0e+00 LRRC37A2
Forced vital capacity (FVC) 1.77 7 3 6.7 -0.49 2.6e-01 ARPC5L CASC10 GAPVD1 LRRC37A2 NOB1 RHOA RTEL1
Heel bone mineral density (BMD) T-score, automated (right) 1.45 2 1 2.2 0.00 1.0e+00 RERE TDRD9
Qualifications: None of the above 2.93 11 5 11.1 0.97 5.5e-07 ACTR1A BAI2 CELF2 ELOVL7 HYAL3 RHOA SEMA6D ST3GAL3 SUOX TANK WDR24
Financial difficulties in last 2 years 2.99 3 0 0.0 1.00 4.4e-03 KLC1 PPP1R13B XRCC3
Mouth/teeth dental problems 2.96 6 1 2.2 -0.84 9.7e-03 EPHX2 KLC1 LRRC37A2 PPP1R13B TDRD9 XRCC3
Heart attack 1.82 2 0 0.0 0.00 1.0e+00 FES NOB1
Allergy 2.34 6 5 11.1 -0.24 6.4e-01 PGAP3 RERE RTEL1 SUOX UNC119B WBP1L
Hayfever/allergic rhinitis (self-reported) 1.30 1 0 0.0 0.00 1.0e+00 SUOX
Medication: Ramipril 1.40 1 0 0.0 0.00 1.0e+00 FES
Medication: Simvastatin 0.99 1 1 2.2 0.00 1.0e+00 FES
Fluid intelligence score 2.22 5 2 4.4 -0.99 4.5e-04 CELF2 PIK3C2A ST3GAL3 TANK TOP2B
Illnesses of siblings 1.77 1 0 0.0 0.00 1.0e+00 FES
Neuroticism score 2.27 4 1 2.2 -0.12 8.8e-01 CELF2 CTTNBP2 LRRC37A2 RERE
Weight 2.46 20 12 26.7 0.86 3.6e-07 ACTR1A AGBL4 AS3MT BAI2 BDNF-AS C10orf32 C2orf60 CADM2 CASC10 CPSF4 GAPVD1 LIN7C MAP2K5 NPM1 NT5C2 PDE4B PHC2 SPG7 STX1B SUOX
Impedance of arm (right) 2.13 17 13 28.9 -0.53 2.3e-02 ACTR1A BDNF-AS C2orf60 CADM2 CASC10 GAPVD1 HYAL3 IMMP2L KCNAB3 LIN7C LRRC37A2 PHC2 PIK3C2A PPM1M RHOA SUOX USP14
Arm fat percentage (right) 2.78 22 12 26.7 0.74 3.2e-05 AGBL4 AS3MT BAI2 BDNF-AS BTRC CASC10 CPSF4 KLC1 LIN7C MAP2K5 NOB1 NPM1 PDE4B PPP1R13B RERE RHOA SEMA6D SPG7 SRR STX1B TDRD9 XRCC3
Trunk fat-free mass 1.99 17 10 22.2 0.52 2.4e-02 ACTR1A AGBL4 ARPC5L AS3MT BDNF-AS C10orf32 C2orf60 CADM2 DESI1 GAPVD1 LIN7C NT5C2 PHC2 SPG7 SUOX WBP1L WDR24
Hip circumference 2.53 18 10 22.2 0.76 9.7e-05 ACTR1A AGBL4 AS3MT BAI2 BDNF-AS C10orf32 CADM2 CASC10 CPSF4 GAPVD1 LIN7C MAP2K5 NPM1 NRXN2 PDE4B PHC2 RTEL1 STX1B
Time employed in main current job 1.15 1 0 0.0 0.00 1.0e+00 LRRC37A2
Alcohol intake versus 10 years previously 2.47 3 2 4.4 0.00 1.0e+00 CLU EPHX2 UNC119B
Father's age at death 1.87 1 0 0.0 0.00 1.0e+00 FES
Worrier / anxious feelings 3.47 8 5 11.1 -0.95 1.7e-05 ACTR1A AS3MT C10orf32 CADM2 LRRC37A2 NOB1 NT5C2 TMEM161B-AS1
Frequency of tiredness / lethargy in last 2 weeks 2.24 3 0 0.0 0.00 1.0e+00 LIN7C RERE XRCC3
Hair/balding pattern: Pattern 3 1.53 1 1 2.2 0.00 1.0e+00 LRRC37A2
Number of live births 1.56 1 1 2.2 0.00 1.0e+00 CADM2
Forced expiratory volume in 1-second (FEV1) 2.08 6 4 8.9 -0.26 6.2e-01 ARPC5L GAPVD1 LRRC37A2 NOB1 RHOA SUOX
Pulse rate 1.57 1 0 0.0 0.00 1.0e+00 MAPKAP1
Qualifications: A levels/AS levels or equivalent 2.76 10 4 8.9 -0.98 3.2e-07 ACTR1A BAI2 CELF2 ELOVL7 RHOA RRP7B ST3GAL3 SUOX TANK WDR24
Mouth/teeth dental problems: Dentures 2.26 4 0 0.0 1.00 2.3e-03 EPHX2 PGAP3 PIK3C2A RHOA
Asthma 2.18 4 3 6.7 -0.26 7.4e-01 MAP2K5 PGAP3 RERE SUOX
Medication: Cholesterol lowering 1.08 1 1 2.2 0.00 1.0e+00 FES
Depression (self-reported) 1.26 1 0 0.0 0.00 1.0e+00 RERE
Lung cancer (father) 2.08 1 0 0.0 0.00 1.0e+00 TDRD9
Illnesses of mother 1.55 1 1 2.2 0.00 1.0e+00 FES
Forced expiratory volume in 1-second (FEV1), Best measure 1.78 5 2 4.4 -0.11 8.7e-01 ARPC5L LRRC37A2 NOB1 RHOA SUOX
Pulse wave Arterial Stiffness index 1.88 1 0 0.0 0.00 1.0e+00 PHC2
Impedance of arm (left) 2.14 19 10 22.2 -0.72 5.7e-04 ACTR1A AGBL4 AS3MT BDNF-AS C2orf60 CADM2 CASC10 CPSF4 GAPVD1 HYAL3 KCNAB3 LIN7C LRRC37A2 PHC2 PIK3C2A PPM1M RHOA SUOX USP14
Arm fat mass (right) 2.80 24 11 24.4 0.80 3.0e-06 AGBL4 AS3MT BAI2 BDNF-AS CADM2 CASC10 CPSF4 KLC1 LIN7C MAP2K5 NOB1 NPM1 PDE4B PHC2 PPP1R13B RERE RHOA SEMA6D SPG7 SRR STX1B SUOX TDRD9 XRCC3
Trunk predicted mass 2.00 17 10 22.2 0.51 2.5e-02 ACTR1A AGBL4 ARPC5L AS3MT BDNF-AS C10orf32 C2orf60 CADM2 DESI1 GAPVD1 LIN7C NT5C2 PHC2 SPG7 SUOX WBP1L WDR24
Standing height 1.46 23 16 35.6 -0.19 3.6e-01 ARPC5L AS3MT C10orf32 COQ5 CPSF4 DESI1 DLX5 GAPVD1 LRRC37A2 MAPKAP1 NOB1 NT5C2 PHC2 PIK3C2A PPM1M RHOA RP11-18I14.10 SPG7 TDRD9 UNC119B WBP1L WDR24 XRCC3
Tense / 'highly strung' 1.69 2 0 0.0 0.00 1.0e+00 CADM2 RERE
Seen doctor (GP) for nerves, anxiety, tension or depression 2.36 2 0 0.0 0.00 1.0e+00 CTTNBP2 LINC00899
Hair/balding pattern: Pattern 4 1.87 3 2 4.4 0.00 1.0e+00 LRRC37A2 RERE SRR
Birth weight of first child 2.21 4 3 6.7 0.56 2.5e-01 AS3MT FES NT5C2 SUOX
Peak expiratory flow (PEF) 2.07 6 3 6.7 -0.36 4.2e-01 ARPC5L C10orf32 GAPVD1 LRRC37A2 PPP6C TOP2B
Pulse wave reflection index 1.84 1 0 0.0 0.00 1.0e+00 HYAL3
Qualifications: O levels/GCSEs or equivalent 2.02 1 0 0.0 0.00 1.0e+00 RHOA
Medication: Paracetamol 2.23 2 1 2.2 0.00 1.0e+00 CASC10 LRRC37A2
Headache pain in last month 1.89 1 1 2.2 0.00 1.0e+00 LRRC37A2
Medication for cholesterol, blood pressure or diabetes 1.68 1 1 2.2 0.00 1.0e+00 FES
Gout (self-reported) 1.63 2 1 2.2 0.00 1.0e+00 CCDC88B NRXN2
Hypothyroidism/myxoedema (self-reported) 1.29 3 1 2.2 0.00 1.0e+00 CCDC88B SUOX TANK
Medication: Amlodipine 1.42 1 1 2.2 0.00 1.0e+00 FES
Medication: Ventolin 100micrograms inhaler 1.34 1 1 2.2 0.00 1.0e+00 PGAP3
Birth weight 1.78 6 2 4.4 0.33 4.7e-01 AS3MT FES LINC00899 NT5C2 SRR SUOX
Chronic bronchitis/emphysema (mother) 1.81 2 0 0.0 0.00 1.0e+00 MAP2K5 TOP2B
High blood pressure (siblings) 2.11 2 1 2.2 0.00 1.0e+00 FES TDRD9
Forced vital capacity (FVC), Best measure 1.64 6 3 6.7 -0.36 4.8e-01 CASC10 LRRC37A2 MSH6 NOB1 RHOA RTEL1
Body fat percentage 2.52 17 9 20.0 0.85 1.9e-05 AGBL4 BAI2 BDNF-AS BTRC CASC10 CPSF4 GTF3C6 LIN7C LRRC37A2 MAP2K5 NPM1 PDE4B RERE RTEL1 SRR STX1B TDRD9
Leg fat percentage (right) 2.75 18 9 20.0 0.92 1.6e-08 AGBL4 BAI2 BDNF-AS CADM2 CASC10 CPSF4 GTF3C6 LIN7C MAP2K5 MAPKAP1 NPM1 PDE4B RERE RHOA RP11-122A3.2 RTEL1 STX1B WDR24
Arm fat-free mass (right) 2.24 18 11 24.4 0.69 8.6e-04 ACTR1A AGBL4 ARPC5L AS3MT BAI2 BDNF-AS C10orf32 C2orf60 CADM2 CASC10 GAPVD1 IMMP2L LIN7C NT5C2 PHC2 SPG7 STX1B SUOX
Exposure to tobacco smoke outside home 2.71 4 0 0.0 0.97 3.5e-02 ACTR1A CTTNBP2 ELOVL7 LIN7C
Comparative body size at age 10 1.94 7 4 8.9 0.67 9.9e-02 CADM2 HYAL3 LIN7C MAP2K5 PPM1M RHOA SRR
Number of full brothers 2.18 1 0 0.0 0.00 1.0e+00 LRRC37A2
Worry too long after embarrassment 2.07 2 0 0.0 0.00 1.0e+00 GAPVD1 LRRC37A2
Wheeze or whistling in the chest in last year 2.50 6 2 4.4 0.98 5.2e-04 BAI2 BDNF-AS LIN7C PGAP3 RERE RTEL1
Number of children fathered 1.68 1 1 2.2 0.00 1.0e+00 CADM2
Reason for reducing amount of alcohol drunk: Health precaution 1.22 1 0 0.0 0.00 1.0e+00 SUOX
Age at first live birth 2.02 2 0 0.0 0.00 1.0e+00 BAI2 WDR24
Pulse wave peak to peak time 2.10 1 0 0.0 0.00 1.0e+00 AS3MT
Shortness of breath walking on level ground 1.38 1 0 0.0 0.00 1.0e+00 COMMD7
Qualifications: College or University degree 3.47 18 11 24.4 -0.88 1.6e-06 ACTR1A BAI2 CADM2 CASC10 CELF2 CTTNBP2 ELOVL7 HYAL3 LRRC37A2 RHOA RRP7B RTEL1 SDK1 SEMA6D ST3GAL3 SUOX TANK WDR24
Medication for pain relief, constipation, heartburn 2.02 1 0 0.0 0.00 1.0e+00 LRRC37A2
Neck or shoulder pain in last month 1.64 1 0 0.0 0.00 1.0e+00 SUOX
Medication: Blood pressure 1.73 1 1 2.2 0.00 1.0e+00 FES
Angina (self-reported) 1.61 1 1 2.2 0.00 1.0e+00 FES
Medication: Allopurinol 1.37 1 1 2.2 0.00 1.0e+00 NRXN2
Mean time to correctly identify matches 1.75 2 0 0.0 0.00 1.0e+00 AGBL4 COMMD7
Whole body fat mass 2.69 18 12 26.7 0.93 9.5e-09 AGBL4 AS3MT BAI2 BDNF-AS CADM2 CASC10 CPSF4 GTF3C6 LIN7C MAP2K5 NPM1 PDE4B PHC2 RERE RHOA RTEL1 SPG7 STX1B
Leg fat mass (right) 3.10 19 13 28.9 0.94 1.2e-09 ACTR1A AGBL4 AS3MT BAI2 BDNF-AS CADM2 CASC10 CPSF4 GTF3C6 LIN7C MAP2K5 NPM1 PDE4B PHC2 RERE RHOA RTEL1 SPG7 STX1B
Arm predicted mass (right) 2.27 17 13 28.9 0.74 3.0e-04 ACTR1A AGBL4 AS3MT BAI2 BDNF-AS C10orf32 C2orf60 CADM2 CASC10 GAPVD1 IMMP2L LIN7C NT5C2 PHC2 SPG7 STX1B SUOX
Pulse rate, automated reading 2.00 6 3 6.7 -0.56 1.9e-01 CPSF4 HYAL3 MAPKAP1 MSH6 PGAP3 RHOA
Alcohol intake frequency. 1.78 7 2 4.4 -0.09 8.5e-01 CADM2 LRRC37A2 PGAP3 RP11-89K21.1 SUOX TMEM161B-AS1 WDR24
Comparative height size at age 10 1.44 12 7 15.6 -0.45 1.2e-01 COQ5 LRRC37A2 MAPKAP1 PDE4B PIK3C2A PPM1M RP11-18I14.10 ST3GAL3 TDRD9 WBP1L WDR24 XRCC3
Number of full sisters 1.54 1 1 2.2 0.00 1.0e+00 CADM2
Suffer from 'nerves' 2.15 4 1 2.2 -0.99 7.1e-03 AS3MT CADM2 LRRC37A2 RERE
Overall health rating 2.44 7 1 2.2 0.99 6.3e-06 AC110781.3 ARPC5L DLX5 MAPKAP1 SUOX TANK XRCC3
Medication: Aspirin 1.23 1 0 0.0 0.00 1.0e+00 FES
Knee pain experienced in last month 1.57 1 0 0.0 0.00 1.0e+00 AC110781.3
Hypertension (Self-reported) 2.29 7 1 2.2 -0.16 7.2e-01 FES MAPKAP1 PDXDC2P RERE RP11-18I14.10 SRR SUOX
Illnesses of father: Heart disease 1.75 3 1 2.2 0.00 1.0e+00 CORO1C FES LRRC37A2
Smoking status: Previous 6.61 16 3 6.7 0.98 7.3e-11 ACTR1A C10orf32 CADM2 CASC10 COMMD7 GTF3C6 HYAL3 KIAA1908 MSH6 NCAM1 NOB1 PHC2 RP11-89K21.1 SDK1 STX1B WBP1L
Forced expiratory volume in 1-second (FEV1), predicted 1.36 2 0 0.0 0.00 1.0e+00 RP11-18I14.10 WBP1L
Whole body fat-free mass 2.08 17 11 24.4 0.54 1.5e-02 ACTR1A AGBL4 ARPC5L AS3MT BAI2 BDNF-AS C10orf32 C2orf60 CADM2 DESI1 GAPVD1 LIN7C NT5C2 PHC2 SPG7 SUOX WDR24
Leg fat-free mass (right) 2.09 19 11 24.4 0.56 6.7e-03 ACTR1A AGBL4 ARPC5L AS3MT BAI2 BDNF-AS C10orf32 C2orf60 CADM2 DESI1 GAPVD1 LIN7C MAP2K5 NPM1 NT5C2 PHC2 SPG7 SUOX WDR24
Arm fat percentage (left) 2.68 20 10 22.2 0.71 2.1e-04 AGBL4 AS3MT BAI2 BDNF-AS BTRC CASC10 CPSF4 KLC1 LIN7C MAP2K5 NOB1 NPM1 PDE4B RERE RHOA SEMA6D SRR STX1B TDRD9 XRCC3
Handedness (chirality/laterality): Left-handed 1.59 1 1 2.2 0.00 1.0e+00 LRRC37A2
Mood swings 1.91 4 1 2.2 0.45 5.5e-01 CELF2 CTTNBP2 LRRC37A2 RHOA
Loneliness, isolation 1.89 2 0 0.0 0.00 1.0e+00 LRRC37A2 RERE
Long-standing illness, disability or infirmity 2.59 2 0 0.0 0.00 1.0e+00 KLC1 XRCC3
Qualifications: nursing, teaching 2.30 1 0 0.0 0.00 1.0e+00 CADM2
Mouth/teeth dental problems: Mouth ulcers 1.13 1 1 2.2 0.00 1.0e+00 LRRC37A2
Asthma (self-reported) 2.23 4 3 6.7 -0.27 7.3e-01 MAP2K5 PGAP3 RERE SUOX
Osteoporosis (self-reported) 1.19 1 0 0.0 0.00 1.0e+00 CCDC88B
Medication: Aspirin 1.21 1 1 2.2 0.00 1.0e+00 FES
Illnesses of father: None of the above (group 1) 1.27 1 1 2.2 0.00 1.0e+00 FES
Smoking status: Current 8.76 30 9 20.0 0.99 1.8e-27 ACTR1A AGBL4 ARPC5L AS3MT C10orf32 C12orf43 CLU COQ5 CORO1C CTTNBP2 CYP2D8P1 DESI1 EPHX2 GAPVD1 GTF3C6 KLC1 MAPKAP1 NT5C2 PIK3C2A PPP1R13B PPP6C RHOA RP11-89K21.1 RRP7B RTEL1 SEMA6D SRR ST3GAL3 TDRD9 XRCC3
Forced expiratory volume in 1-second (FEV1), predicted percentage 1.92 3 2 4.4 0.00 1.0e+00 LRRC37A2 PGAP3 TOP2B
Whole body water mass 2.06 17 12 26.7 0.54 1.5e-02 ACTR1A AGBL4 ARPC5L AS3MT BAI2 BDNF-AS C10orf32 C2orf60 CADM2 DESI1 GAPVD1 LIN7C NT5C2 PHC2 SPG7 SUOX WDR24
Leg predicted mass (right) 2.09 19 11 24.4 0.56 6.5e-03 ACTR1A AGBL4 ARPC5L AS3MT BAI2 BDNF-AS C10orf32 C2orf60 CADM2 DESI1 GAPVD1 LIN7C MAP2K5 NPM1 NT5C2 PHC2 SPG7 SUOX WDR24
Arm fat mass (left) 2.82 23 11 24.4 0.85 2.7e-07 ACTR1A AGBL4 AS3MT BAI2 BDNF-AS C2orf60 CADM2 CASC10 CPSF4 KLC1 LIN7C MAP2K5 NOB1 NPM1 PDE4B PHC2 RERE RHOA SEMA6D SPG7 STX1B TDRD9 XRCC3
Number of self-reported non-cancer illnesses 2.12 1 0 0.0 0.00 1.0e+00 TDRD9
Average weekly champagne plus white wine intake 2.04 3 0 0.0 0.00 1.0e+00 RERE SUOX WDR24
Miserableness 1.94 6 1 2.2 0.37 4.8e-01 CELF2 CTTNBP2 LRRC37A2 RERE RHOA TANK
Guilty feelings 1.62 1 0 0.0 0.00 1.0e+00 LRRC37A2
Wears glasses or contact lenses 1.40 1 0 0.0 0.00 1.0e+00 CADM2
Mother's age at death 1.89 1 0 0.0 0.00 1.0e+00 MAPKAP1
Medication: Blood pressure 1.79 1 1 2.2 0.00 1.0e+00 FES
Medication: Bendroflumethiazide 1.55 1 0 0.0 0.00 1.0e+00 FES
Medication: Paracetamol 2.00 4 0 0.0 -0.99 1.1e-02 CASC10 COMMD7 LRRC37A2 RHOA
Illnesses of father: High blood pressure 1.92 1 1 2.2 0.00 1.0e+00 FES
Alcohol drinker status: Never 1.50 1 0 0.0 0.00 1.0e+00 CADM2
Ever smoked 9.72 34 15 33.3 0.99 2.0e-32 AC110781.3 ACTR1A AS3MT C10orf32 C2orf60 CADM2 COMMD7 CPSF4 CTTNBP2 ELOVL7 GAPVD1 GTF3C6 HYAL3 KIAA1908 LINC00899 MAP2K5 MSH6 NCAM1 NOB1 NRXN2 NT5C2 PDE4B PDXDC2P PGAP3 PHC2 PPP6C RP11-89K21.1 SDK1 SRR STX1B TMEM161B-AS1 TOP2B WBP1L WDR24
Basal metabolic rate 2.17 20 12 26.7 0.64 9.3e-04 ACTR1A AGBL4 ARPC5L AS3MT BAI2 BDNF-AS C10orf32 C2orf60 CADM2 CASC10 DESI1 GAPVD1 LIN7C MAP2K5 NT5C2 PDE4B PHC2 SPG7 STX1B SUOX
Leg fat percentage (left) 2.80 18 9 20.0 0.93 1.3e-08 AGBL4 BAI2 BDNF-AS CADM2 CASC10 CPSF4 GTF3C6 LIN7C MAP2K5 MAPKAP1 NPM1 PDE4B RERE RHOA RTEL1 STX1B TDRD9 WDR24
Arm fat-free mass (left) 2.21 17 12 26.7 0.68 1.3e-03 ACTR1A AGBL4 AS3MT BAI2 BDNF-AS C10orf32 C2orf60 CADM2 CASC10 DESI1 GAPVD1 LIN7C NT5C2 PHC2 SPG7 STX1B SUOX
Number of operations (self-reported) 1.70 3 1 2.2 0.00 1.0e+00 CASC10 HYAL3 TANK
Average weekly beer plus cider intake 2.25 2 0 0.0 0.00 1.0e+00 BDNF-AS RP11-89K21.1
Irritability 1.85 1 1 2.2 0.00 1.0e+00 LRRC37A2
Risk taking 3.70 7 2 4.4 0.97 8.3e-05 CADM2 KLC1 LINC00899 PPP1R13B RP11-89K21.1 TDRD9 XRCC3
Age started oral contraceptive pill 2.09 1 0 0.0 0.00 1.0e+00 IMMP2L
Diastolic blood pressure, automated reading 2.25 8 3 6.7 0.07 8.6e-01 CASC10 FES MAP2K5 MAPKAP1 RERE RTEL1 SRR TDRD9
Ever depressed for a whole week 1.83 1 0 0.0 0.00 1.0e+00 HYAL3
Vascular/heart problems diagnosed by doctor 2.38 7 1 2.2 -0.13 7.5e-01 FES MAP2K5 RERE RP11-18I14.10 SRR SUOX XRCC3
Pain experienced in last month 2.50 7 1 2.2 -0.94 1.5e-03 ARPC5L COMMD7 GAPVD1 NPM1 PPP6C RHOA SUOX
Heart attack/myocardial infarction (self-reported) 1.73 1 0 0.0 0.00 1.0e+00 FES
Heart disease (siblings) 1.38 1 0 0.0 0.00 1.0e+00 FES
Alcohol drinker status: Previous 1.83 1 0 0.0 0.00 1.0e+00 XRCC3
Pack years of smoking 2.94 3 0 0.0 0.00 1.0e+00 AGBL4 KLC1 XRCC3
Impedance of whole body 2.21 15 13 28.9 -0.62 9.8e-03 ACTR1A AS3MT BDNF-AS C2orf60 CADM2 CPSF4 GAPVD1 HYAL3 LIN7C LRRC37A2 PHC2 PIK3C2A PPM1M RHOA SUOX
Leg fat mass (left) 3.10 19 13 28.9 0.94 1.0e-09 ACTR1A AGBL4 AS3MT BAI2 BDNF-AS CADM2 CASC10 CPSF4 GTF3C6 LIN7C MAP2K5 NPM1 PDE4B PHC2 RERE RHOA RTEL1 SPG7 STX1B
Arm predicted mass (left) 2.21 17 11 24.4 0.68 1.4e-03 ACTR1A AGBL4 ARPC5L AS3MT BAI2 BDNF-AS C10orf32 C2orf60 CADM2 CASC10 GAPVD1 LIN7C NT5C2 PHC2 SPG7 STX1B SUOX

Associations by panel

study tissue # hits % hits/tests avg chisq
GTEx Adipose Subcutaneous 27 0.77 2.5
GTEx Adipose Visceral Omentum 12 0.59 2.5
GTEx Adrenal Gland 4 0.27 2.4
GTEx Artery Aorta 17 0.57 2.4
GTEx Artery Coronary 8 0.68 2.5
GTEx Artery Tibial 23 0.61 2.4
GTEx Brain Caudate basal ganglia 4 0.43 2.5
GTEx Brain Cerebellar Hemisphere 7 0.47 2.6
GTEx Brain Cerebellum 11 0.55 2.6
GTEx Brain Cortex 4 0.39 2.8
GTEx Brain Frontal Cortex BA9 4 0.43 2.7
GTEx Brain Hippocampus 3 0.57 2.7
GTEx Brain Hypothalamus 4 0.68 2.7
GTEx Brain Nucleus accumbens basal ganglia 5 0.58 2.6
GTEx Brain Putamen basal ganglia 4 0.64 2.4
GTEx Breast Mammary Tissue 13 0.66 2.5
GTEx Breast Mammary Tissue (Male) 4 0.34 2.3
GTEx Breast Mammary Tissue (Female) 11 0.67 2.4
GTEx Cells EBV-transformed lymphocytes 11 0.77 2.6
GTEx Cells Transformed fibroblasts 23 0.55 2.5
GTEx Colon Sigmoid 9 0.62 2.4
GTEx Colon Transverse 8 0.39 2.4
GTEx Esophagus Gastroesophageal Junction 10 0.69 2.4
GTEx Esophagus Mucosa 13 0.39 2.4
GTEx Esophagus Muscularis 12 0.37 2.5
GTEx Heart Atrial Appendage 9 0.57 2.5
GTEx Heart Left Ventricle 9 0.59 2.6
GTEx Liver 5 0.70 2.8
GTEx Lung 14 0.49 2.5
GTEx Muscle Skeletal 18 0.62 2.6
GTEx Nerve Tibial 20 0.46 2.4
GTEx Ovary 9 0.99 2.6
GTEx Pancreas 8 0.49 2.5
GTEx Pituitary 5 0.45 2.6
GTEx Prostate 5 0.60 2.6
GTEx Skin Not Sun Exposed Suprapubic 13 0.53 2.5
GTEx Skin Sun Exposed Lower leg 22 0.60 2.5
GTEx Small Intestine Terminal Ileum 1 0.22 2.6
GTEx Spleen 5 0.35 2.5
GTEx Stomach 8 0.55 2.5
GTEx Testis 11 0.35 2.4
GTEx Thyroid 19 0.48 2.5
GTEx Uterus 8 1.41 2.7
GTEx Vagina 2 0.31 2.2
GTEx Whole Blood 12 0.60 2.5
METSIM Adipose 23 0.50 2.4
NTR Blood 13 0.54 2.2
ROSMAP Brain Pre-frontal Cortex 17 0.39 2.4
YFS Blood 13 0.28 2.2
CommonMind Brain Pre-frontal Cortex 20 0.37 2.4
The Cancer Genome Atlas Bladder Urothelial Carcinoma 5 0.30 2.2
The Cancer Genome Atlas Breast Invasive Carcinoma 19 0.43 2.3
The Cancer Genome Atlas Cervical Squamous Cell Carcinoma 6 0.54 2.4
The Cancer Genome Atlas Colon Adenocarcinoma 13 0.63 2.3
The Cancer Genome Atlas Esophageal Carcinoma 2 0.29 2.5
The Cancer Genome Atlas Glioblastoma Multiforme 9 0.88 2.6
The Cancer Genome Atlas Head and Neck Squamous Cell Carcinoma 11 0.40 2.3
The Cancer Genome Atlas Kidney Renal Clear Cell Carcinoma 14 0.34 2.3
The Cancer Genome Atlas Kidney Renal Papillary Cell Carcinoma 9 0.44 2.3
The Cancer Genome Atlas Brain Lower Grade Glioma 11 0.26 2.3
The Cancer Genome Atlas Liver Hepatocellular Carcinoma 7 0.63 2.4
The Cancer Genome Atlas Lung Adenocarcinoma 13 0.44 2.3
The Cancer Genome Atlas Lung Squamous Cell Carcinoma 10 0.40 2.3
The Cancer Genome Atlas Ovarian Serous Cystadenocarcinoma 7 0.44 2.5
The Cancer Genome Atlas Pancreatic Adenocarcinoma 6 0.36 2.2
The Cancer Genome Atlas Pheochromocytoma and Paraganglioma 7 0.53 2.4
The Cancer Genome Atlas Prostate Adenocarcinoma 18 0.39 2.2
The Cancer Genome Atlas Rectum Adenocarcinoma 4 0.57 2.3
The Cancer Genome Atlas Soft Tissue Sarcoma 6 0.56 2.4
The Cancer Genome Atlas Skin Cutaneous Melanoma 2 0.37 2.3
The Cancer Genome Atlas Stomach Adenocarcinoma 3 0.18 2.3
The Cancer Genome Atlas Testicular Germ Cell Tumors 2 0.16 2.3
The Cancer Genome Atlas Thyroid Carcinoma 17 0.33 2.3
The Cancer Genome Atlas Uterine Corpus Endometrial Carcinoma 1 0.20 2.3